Nasdaq:US$14.43 (-0.28) | HKEX:HK$23.18 (+0.30) | AIM:£2.21 (+0.02)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702